Butterfly Network (BFLY) Short-term Investments (2021 - 2022)
Butterfly Network recorded quarterly Short-term Investments of $75.2 million in Q4 2022, up 0.94% quarter-over-quarter from $74.5 million in Q3 2022.
Butterfly Network's Short-term Investments history runs 2 years deep, the most recent figure standing at $75.2 million for Q4 2022.
- In Q4 2022, Short-term Investments changed N/A year-over-year to $75.2 million; the TTM figure through Dec 2022 stood at $75.2 million (changed N/A YoY), while the FY2022 annual figure was $75.2 million, changed N/A from the prior year.
- Short-term Investments came in at $75.2 million for Q4 2022 at Butterfly Network, up from $74.5 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $526.4 million in Q1 2021 to a low of $74.5 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Butterfly Network | 1.17 Bn | 1.04 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 75.25 Mn |
| Sep 30, 2022 | 74.55 Mn |
| Sep 30, 2021 | 315.10 Mn |
| Jun 30, 2021 | 489.89 Mn |
| Mar 31, 2021 | 526.44 Mn |